Skip to main content
Michael Klompas, MD, Infectious Disease, Boston, MA

MichaelKlompasMD

Infectious Disease Boston, MA

Professor of Population Medicine

Dr. Klompas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Klompas' full profile

Already have an account?

  • Office

    15 Francis St
    Pbb-4
    Boston, MA 02115
    Phone+1 617-732-8881
    Fax+1 617-726-7416

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2004 - 2008
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center  
    Chanu Rhee, Michael Klompas, JAMA Network Open
  • Airborne Transmission of SARS-CoV-2  
    Michael Klompas, Meghan A Baker, Chanu Rhee, JAMA
  • Universal Masking in Hospitals in the Covid-19 Era  
    Michael Klompas, Erica S Shenoy, The New England Journal of Medicine
  • Join now to see all

Authored Content

  • Airborne Transmission of SARS-CoV-2July 2020
  • Antibiotics for Sepsis—Finding the EquilibriumSeptember 2018

Press Mentions

  • Study Casts More Doubt on Benefits of CMS Sepsis Bundle
    Study Casts More Doubt on Benefits of CMS Sepsis BundleMarch 21st, 2025
  • New Study Challenges Assumptions About SEP-1 Bundle Compliance and Sepsis Outcomes
    New Study Challenges Assumptions About SEP-1 Bundle Compliance and Sepsis OutcomesMarch 19th, 2025
  • Study Finds Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity
    Study Finds Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to MorbidityJuly 16th, 2024
  • Join now to see all

Grant Support

  • RFA-CK20-004: Epicenter V: Harvard Pilgrim Health Care Institute Center for Excellence in HAI Surveillance and PreventionHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Reliability and Validity Testing for a Risk-Adjusted Community-Onset Adult Sepsis Event Mortality MeasureHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • RFA-CK20-004: Epicenter V: Harvard Pilgrim Health Care Institute Center for Excellence in HAI Surveillance and PreventionHARVARD PILGRIM HEALTH CARE, INC.2021–2026
  • Developing Evidence-Based Sepsis Time Zero Criteria and Quality Metrics Using Electronic Health Record DataHARVARD PILGRIM HEALTH CARE, INC.2020–2025